Skip to main content
SpringerLink
Log in

PET/CT in Follicular Cancer Including Hürthle Cell Cancer

  • Chapter
  • First Online:
Thyroid Cancer

  • 153 Accesses

Abstract

The role of positron emission tomography (PET) and computer tomography (CT) using 18F-fluorodeoxyglucose (18F-FDG) was reviewed in depth in the section on differentiated thyroid cancer. The main role of 18F-FDG PET-CT is in helping to identify the source of thyroglobulin (Tg) production in a patient whose cancer does not take up radioiodine. Most of the references cited in the earlier chapter included patients with both papillary and follicular cancers, and in most cases, it is not possible to separate these two cancer types and analyze the results. For example, Dietlein et al. presented results in 58 patients, 38 of whom had papillary cancer, 15 had follicular cancer, and 5 had variants of follicular cancer. In another paper there were 11 follicular and 3 Hürthle cell cancers out of a total of 51 patients. Some of the reports simply state that patients had papillary or follicular cancer. Some studies even include patients with anaplastic cancer as well as differentiated cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dietlein M, Scheidhauer K, Voth E, Theissen P, Schicha H. Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer. Eur J Nucl Med. 1997;24:1342–8.

    Article  CAS  PubMed  Google Scholar 

  2. Giammarile F, Hafdi Z, Bournaud C, et al. Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake? Eur J Endocrinol. 2003;149:293–300.

    Article  CAS  PubMed  Google Scholar 

  3. Conti PS, Durski JM, Bacqai F, Grafton ST, Singer PA. Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography. Thyroid. 1999;9:797–804.

    Article  CAS  PubMed  Google Scholar 

  4. Fridrich L, Messa C, Landoni C, et al. Whole-body scintigraphy with 99mTc-MIBI, 18F-FDG-PET and 131I in patients with metastatic thyroid carcinoma. Nucl Med Commun. 1997;18:3–9.

    Google Scholar 

  5. Grunwald F, Kalicke T, Feine U, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med. 1999;26:1547–52.

    Article  CAS  PubMed  Google Scholar 

  6. Dong MJ, Liu ZF, Zhao K, Ruan LX, Wang GL, Yang SY, Sun F, Luo XG. Value of 18F-FDG PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis. Nucl Med Commun. 2009;30:639–50.

    Article  PubMed  Google Scholar 

  7. Blount CL, Dworkin HJ. F-18 FDG uptake by recurrent Hürthle cell carcinoma of the thyroid using high-energy planar scintigraphy. Clin Nucl Med. 1996;21:831–3.

    Article  CAS  PubMed  Google Scholar 

  8. Wiesner W, Engel H, von Schulthess GK, Krestin GP, Bicik I. FDG PET-negative liver metastases of a malignant melanoma and F-FDG PET-positive Hürthle cell tumor of the thyroid. Eur Radiol. 1999;9:975–8.

    Article  CAS  PubMed  Google Scholar 

  9. Plotkin M, Hautzel H, Krause BJ, et al. Implication of 2-18fluor-2-deoxyglucose positron emission tomography in the follow-up of Hurthle cell thyroid cancer. Thyroid. 2002;12:155–61.

    Google Scholar 

  10. Lowe VJ, Mullan BP, Hay ID, McIver B, Kasperbauer JL. 18F-FDG PET of patients with Hurthle cell carcinoma. J Nucl Med. 2003;44:1402–6.

    PubMed  Google Scholar 

  11. Pryma DA, Schöder H, Gönen M, Robbins RJ, Larson SM, Yeung HWD. Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients. J Nucl Med. 2006;47:1260–6.

    PubMed  Google Scholar 

  12. Treglia G, Annunziata S, Muoio B, Salvatori M, Ceriani L, Giovanella L. The role of fluorine-18-fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer: an overview. Int J Endocrinol. 2013;2013:856189.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Nuclear Medicine, Stanford University Hospital and Clinics, Stanford, CA, USA

    Iain Ross McDougall MD, PhD, FRCP

  2. Department of Radiology, Nuclear Medicine, Stanford University Medical Center, Stanford School of Medicine, 300 Pasteur Dr, H2230 MC 5281, Stanford, CA, 94305, USA

    Andrei Iagaru MD

Authors
  1. Iain Ross McDougall MD, PhD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrei Iagaru MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrei Iagaru MD .

Editor information

Editors and Affiliations

  1. Department of Medicine, MedStar Washington Hospital Center Georgetown University School of Medicine, Washington, DC, USA

    Leonard Wartofsky

  2. Nuclear Medicine Research MedStar Research Institute and Washington Hospital Center, Georgetown University School of Medicine Washington Hospital Center, Washington, DC, USA

    Douglas Van Nostrand

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

McDougall, I.R., Iagaru, A. (2016). PET/CT in Follicular Cancer Including Hürthle Cell Cancer. In: Wartofsky, L., Van Nostrand, D. (eds) Thyroid Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3314-3_76

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3314-3_76

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3312-9

  • Online ISBN: 978-1-4939-3314-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation